Freeline Announces August 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy
Freeline Receives Approval to Transfer to Nasdaq Capital Market
Freeline Announces FDA Clearance of Investigational New Drug Application for FLT201 for Gaucher Disease Type 1
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease
Freeline Presents Data Highlighting Platform Technology at the American Society of Gene and Cell Therapy Annual Meeting 2021
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels